Document is current
Any future updates will be listed below
-
Authors
Padoa, Anna https://orcid.org/0000-0002-9032-3852
Tomashev, Roni
Brenner, Inbal
Fligelman, Tal
Golan, Ayelet
Igawa, May Shir
Lurie, B. A. Ido
Talmon, Anat
Ginzburg, Karni
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 16 December 2025
First Online: 22 January 2026
Declarations
:
: All other authors report there are no competing interests to declare.
: Anna Padoa has received speaker honorarium from Pierre Fabre Medicament in 2022, study funding and travel support from Hikkonu, a member of DirexGroup in 2024 and from Freya Pharma in 2025, speaker honorarium from Dexcel Pharma in 2024 and royalties from Springer Switzerland. Dr Padoa is member of the Advisory Board of Tiki100 Ltd. She is unpaid co-chair of the Education Committee at EUGA and chair of the female sexual dysfunction Scientific Committee at ESSM.
